跳至主要内容
临床试验/CTRI/2023/08/056519
CTRI/2023/08/056519尚未招募不适用

Efficacy And Safety Of iPRF(Injectable Platelet Rich Fibrin) As An Adjuvant In Treatment Of Male Patterned Baldness

Krishna Institute of Medical Sciences1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年8月26日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Reduction in hairloss

研究概览

简要总结

This is a randomized comparative study between PRP and iPRF treatments when given as an adjuvant along with topical minoxidil for androgenic alopecia in males. Through this study we will be comparing the efficacy and safety of both the adjuvant treatments and finding out the better one for the treatment of androgenic alopecia.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
Male

入选标准

  • Have given written consent before any treatment is commenced.
  • Be diagnosed to be suffering from male patterned baldness by assessment through Hamilton and Norwood Scale(Grade 2 to 6) clinically in DERMATOLOGY OPD
  • Have completed 18 years of age.

排除标准

  • Patient having keloid scarring or keloidal tendency.
  • History of bleeding disorder and anticoagulant therapy.
  • Active skin infection over scalp.
  • Patient on any other systemic drugs therapy which in the judgement of investigator may interfere with interpretation of results.
  • Patients with known hypersensitivity to topical anaesthetic agents.

结局指标

主要结局

Reduction in hairloss

时间窗: Reduction in hairloss in 6 months

次要结局

  • identification of better adjuvant(new hair growth in 6 months)

研究者

申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验